Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Providing training and access to standard computing hardware and cloud-based resources can enable scientists in lower-resource institutions and countries to reanalyze published ‘-omics’ data and produce career-enhancing STEM research.
Biomedical research and healthcare has traditionally centered on disease rather than health. Several projects gathering data on healthy people promise to change that.
The FDA approved record numbers of new molecular entities, orphan drugs, small-molecule generics and biosimilars in 2018. Could industry’s regulatory success of the past two years become the new normal?